CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy President and COO bought 2,000 shares at $1.80 ($3,600)
- 4 Open-market buy See Remarks bought 3,000 shares at $2.00 ($6,000)
- 4 Open-market buy Chief Executive Officer bought 2,221 shares at $1.85 ($4,109)
- 4 Open-market buy Chief Executive Officer bought 16,000 shares at $2.17 ($34,784)
- 8-K Event Shareholder vote results
- 4 Open-market buy Chief Financial Officer bought 8,700 shares at $1.90 ($16,529)
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy President and COO bought 5,000 shares at an average $2.03 ($10,164)
- 4 Open-market buy Director bought 11,000 shares at an average $2.19 ($24,130)
- 4 Open-market buy Director bought 1,676 shares at $2.24 ($3,749)
- 4 Open-market buy Director bought 10,000 shares at an average $2.02 ($20,175)
- 4 Open-market buy Director bought 5,000 shares at $1.96 ($9,795)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
Page 12 of 49 · 978 filings